Cargando…
Galacto‐conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity
Pharmacologically active compounds with preferential cytotoxic activity for senescent cells, known as senolytics, can ameliorate or even revert pathological manifestations of senescence in numerous preclinical mouse disease models, including cancer models. However, translation of senolytic therapies...
Autores principales: | González‐Gualda, Estela, Pàez‐Ribes, Marta, Lozano‐Torres, Beatriz, Macias, David, Wilson, Joseph R., González‐López, Cristina, Ou, Hui‐Ling, Mirón‐Barroso, Sofía, Zhang, Zhenguang, Lérida‐Viso, Araceli, Blandez, Juan F., Bernardos, Andrea, Sancenón, Félix, Rovira, Miguel, Fruk, Ljiljana, Martins, Carla P., Serrano, Manuel, Doherty, Gary J., Martínez‐Máñez, Ramón, Muñoz‐Espín, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189993/ https://www.ncbi.nlm.nih.gov/pubmed/32233024 http://dx.doi.org/10.1111/acel.13142 |
Ejemplares similares
-
A Two-Photon Probe Based on Naphthalimide-Styrene
Fluorophore for the In Vivo Tracking of Cellular
Senescence
por: Lozano-Torres, Beatriz, et al.
Publicado: (2021) -
Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax
por: Yamamoto, Masahiro, et al.
Publicado: (2021) -
Targeting senescent cells in translational medicine
por: Paez‐Ribes, Marta, et al.
Publicado: (2019) -
ET-6 Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax
por: Yamamoto, Masahiro, et al.
Publicado: (2021) -
Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors
por: Zhu, Yi, et al.
Publicado: (2016)